Implications of left ventricular remodeling in hypertrophic cardiomyopathy

American Journal of Cardiology

Volumn 81, Issue 11, 1998, Pages 1339-1344

  Maron, Barry J ^a   Spirito, Paolo ^b  

^a MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE COURSE; EDITORIAL; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; PATHOGENESIS; PRIORITY JOURNAL;

ADOLESCENT; ADULT; CARDIOMYOPATHY, HYPERTROPHIC; CHILD; CHILD, PRESCHOOL; FEMALE; HEART VENTRICLES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; INFANT; MALE; PHENOTYPE; PROGNOSIS; VENTRICULAR FUNCTION, LEFT;

EID: 0032103098     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(98)00164-7     Document Type: Editorial

References (78)

1. 1. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction: experimental observations and clinical implications. Circulation 1990;81:1161-1172.
2. 2. Levine HJ, Gaasch WH. Vasoactive drugs in chronic regurgitant lesions of the mitral and aortic valves. J Am Coll Cardiol 1996;28:1083-1091.
3. 3. Giannuzzi P, Tavazzi L, Temporelli PL, Corrà U, Imparato A, Gattone M, Giordano A, Sala L, Schweiger C, Malinverni C. Long-term physical training and left ventricular remodeling after anterior myocardial infarction: results of the exercise in anterior myocardial infarction (EAMI) trial. J Am Coll Cardiol 1993;22:1821-1829.
4. 4. Huston TP, Puffer JC, Rodney WM. The athletic heart syndrome. N Engl J Med 1985;313:24-32.
5. 5. Maron BJ. Structural features of the athlete heart as defined by echocardiography. J Am Coll Cardiol 1986;7:190-203.
6. 6. Pelliccia A, Maron BJ, Culasso F, Spataro A, Caselli G. The athlete's heart in women: echocardiographic characterization of 600 highly trained elite female athletes. JAMA 1996;276:211-215.
7. 7. Pelliccia A, Maron BJ, Spataro A, Proschan MA, Spirito P. The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes. N Engl J Med 1991;324:295-301.
8. 8. Spirito P, Seidman CE, McKenna WJ, Maron BJ. Management of hypertrophic cardiomyopathy. N Engl J Med 1997;336:775-785.
9. 9. Anan R, Greve G, Thierfelder L, Watkins H, McKenna J, Solomon S, Vecchio C, Shono H, Nakao S, Tanaka H, et al. Prognostic implications of novel β cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy. J Clin Invest 1994;93:280-285.
10. 10. Watkins H, McKenna WJ, Thierfelder L, Suk HJ, Anan R, O'Donoghue A, Spirito P, Matsumori A, Moravec CS, Seidman JG, Seidman CE. Mutations in the genes for cardiac troponin T and α-tropomyosin in hypertrophic cardiomyopathy. N Engl J Med 1995;332:1058-1064.
11. 11. Watkins H, Conner D, Thierfelder L, Jarcho JA, Suk HJ, MacRae C, McKenna WJ, Maron BJ, Seidman JG, Seidman CE. Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy. Nat Genet 1995;11:434-437.
12. 12. Marian BJ, Roberts R. Recent advances in the molecular genetics of hypertrophic cardiomyopathy. Circulation 1995;92:1336-1347.
13. 13. Schwartz K, Carrier L, Guicheney P, Komajda M. Molecular basis of familial cardiomyopathies. Circulation 1995;91:532-540.
14. 14. Niimura H, Bachinski LL, Sangwatoraj S, Watkins H, Chudley AE, McKenna W, Kristinson A, Sole M, Roberts R, Maron BJ, Seidman JG, Seidman C: Human cardiac myosin binding protein C mutations cause late-onset familiar hypertrophic cardiomyopathy. N Engl J Med (in press).
15. 15. Wigle ED, Sasson Z, Henderson MA, Ruddy TD, Fulop J, Rakowski H, Williams WG. Hypertrophic cardiomyopathy. The importance of the site and extent of hypertrophy. A review. Prog Cardiovasc Dis 1985;28:1-83.
16. 16. Maron BJ, Bonow RO, Cannon RO III, Leon BJ, Epstein SE. Hypertrophic cardiomyopathy: interrelation of clinical manifestations, pathophysiology, and therapy. N Engl J Med 1987;316:780-789 and 844-852.
17. 17. Wigle ED, Rakowski H, Kimball BP, Williams WG. Hypertrophic cardiomyopathy: clinical spectrum and treatment. Circulation 1995;92:1680-1692.
18. 18. Louie EK, Edwards LC. Hypertrophic cardiomyopathy. Prog Cardiovasc Dis 1994;36:275-308.
19. 19. Hecht GM, Klues HG, Roberts WC, Maron BJ. Coexistence of sudden cardiac death and end-stage heart failure in familial hypertrophic cardiomyopathy. J Am Coll Cardiol 1993;22:489-497.
20. 20. Koga Y, Itaya K-I, Toshima H. Prognosis in hypertrophic cardiomyopathy. Am Heart J 1984;108:351-359.
21. 21. Webb JG, Sasson Z, Rakowski H, Liu P, Wigle ED. Apical hypertrophic cardiomyopathy: clinical follow-up and diagnostic correlates. J Am Coll Cardiol 1990;15:83-90.
22. 22. Spirito P, Maron BJ, Bonow RO, Epstein SE. Occurrence and significance of progressive left ventricular wall thinning and relative cavity dilatation in patients with hypertrophic cardiomyopathy. Am J Cardiol 1987;60:123-129.
23. 23. Maron BJ, Spirito P, Wesley Y, Arce J. Development and progression of left ventricular hypertrophy in children with hypertrophic cardiomyopathy. N Engl J Med 1986;315:610-614.
24. 24. Maron BJ. Hypertrophic cardiomyopathy. Lancet 1997;350:127-133.
25. 25. Fiddler GI, Tajik AJ, Weidman WH, McGoon DC, Ritter DG, Giuliani ER. Idiopathic hypertrophic subaortic stenosis in the young. Am J Cardiol 1978;42: 793-799.
26. 26. McKenna WJ, Deanfield JE. Hypertrophic cardiomyopathy: an important cause of sudden death. Arch Dis Child 1984;59:971-975.
27. 27. Maron BJ, Tajik AJ, Ruttenberg HD, Graham TP, Atwood GF, Victorica BE, Lie JT, Roberts WC. Hypertrophic cardiomyopathy in infants: clinical features and natural history. Circulation 1982;65:7-17.
28. 28. Panza JA, Maris TJ, Maron BJ. Development and determinants of dynamic obstruction to left ventricular outflow in young patients with hypertrophic cardiomyopathy. Circulation 1992;85:1398-1405.
29. 29. Rosenzweig A, Watkins H, Hwang D-S, Miri M, McKenna W, Traill TA, Seidman JG, Seidman CE. Preclinical diagnosis of familial hypertrophic cardiomyopathy by genetic analysis of blood lymphocytes. N Engl J Med 1991;325: 1753-1760.
30. 30. Panza JA, Maron BJ. Relation of electrocardiographic abnormalities to evolving left ventricular hypertrophy in hypertrophic cardiomyopathy. Am J Cardiol 1989;63:1258-1265.
31. 31. Maron BJ, Nichols PF, Pickle LW, Wesley YE, Mulvihill JJ. Patterns of inheritance in hypertrophic cardiomyopathy: assessment by M-mode and two-dimensional echocardiography. Am J Cardiol 1984;53:1087-1094.
32. 32. Roberts CS, Roberts WC. Morphologic features. In: Zipes DP, Rowlands DJ, eds. Progress in Cardiology 2/2. Philadelphia: Lea & Febiger, 1989:3-22.
33. 33. Klues HG, Schiffers A, Maron BJ. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. J Am Coll Cardiol 1995;26:1699-1708.
34. 34. Shapiro LM, McKenna WJ. Distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: a two-dimensional echocardiographic study. J Am Coll Cardiol 1983;2:437-444.
35. 35. Gregor P, Widimský P, Červenka V, Višek V, Hroboňová V. Electrocardiographic changes can precede the development of myocardial hypertrophy in the setting of hypertrophic cardiomyopathy. Int J Cardiol 1989;23:335-341.
36. 36. Spirito P, Maron BJ. Absence of progression of left ventricular hypertrophy in adult patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 1987;9: 1013-1017.
37. 37. Ferrans VJ, Morrow AG, Roberts WC. Myocardial ultrastructure in idiopathic hypertrophic subaortic stenosis: a study of operatively excised left ventricular outflow tract muscle in 14 patients. Circulation 1972;45:769-792.
38. 38. Fujiwara H, Hoshino T, Yamana K, Fujiwara T, Furuta M, Hamashima Y, Kawai C. Number and size of myocytes and amount of interstitial space in the ventricular septum and in the left ventricular free wall in hypertrophic cardiomyopathy. Am J Cardiol 1983;52:818-823.
39. 39. Unverferth DV, Baker PB, Pearce LI, Lautman J, Roberts WC. Regional myocyte hypertrophy and increased interstitial myocardial fibrosis in hypertrophic cardiomyopathy. Am J Cardiol 1987;59:932-936.
40. 40. St. John Sutton MG, Lie JT, Anderson KR, O'Brien PC, Frye RL. Histopathological specificity of hypertrophic obstructive cardiomyopathy. Br Heart J 1980;44:433-443.
41. 41. Maron BJ, Roberts WC. Quantitative analysis of cardiac muscle cell disorganization in the ventricular septum of patients with hypertrophic cardiomyopathy. Circulation 1979;59:689-706.
42. 42. Shirani J, Pick R, Silver MA, Roberts WC, Maron BJ. Importance of collagen matrix in young patients with hypertrophic cardiomyopathy and sudden death (abstr). J Am Coll Cardiol 1994;23(2 suppl):110A.
43. 43. Kaltenbach M, Hopf R, Kober G, Bussmann W-D, Keller M, Petersen Y. Treatment of hypertrophic obstructive cardiomyopathy with verapamil. Br Heart J 1979;42:35-42.
44. 44. Fananapazir L, Epstein ND, Curiel RV, Panza JA, Tripodi D, McAreavey D. Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy: evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy. Circulation 1994;90: 2731-2742.
45. 45. Fujiwara H, Onodera T, Tanaka M, Shirane H, Kato H, Yoshikawa J, Osakada G, Sasayama S, Kawai C. Progression from hypertrophic obstructive cardiomyopathy to typical dilated cardiomyopathy-like features in the end stage. Jpn Circ J 1984;48:1210-1214.
46. 46. Okamoto S, Ozaki M, Konishi T, Nakano T. A case report of siblings with hypertrophic cardiomyopathy that progressed to dilated cardiomyopathy: case reports. Angiology 1993;44:406-411.
47. 47. Waller BF, Maron BJ, Epstein SE, Roberts WC. Transmural myocardial infarction in hypertrophic cardiomyopathy: a cause of conversion from left ventricular asymmetry to symmetry and from normal-sized to dilated left ventricular cavity. Chest 1981;79:461-465.
48. 48. Nagata S, Park Y-D, Sakakibara H, Yutani C, Nimura Y, Mimasu S, Kuniya T, Harada S, Yoshida K. Progressive left ventricular dilatation in a child with hypertrophic cardiomyopathy: a case report. J Cardiol 1986;16(suppl IX):49-55.
49. 49. Kawashima T, Yokota Y, Yokoyama M, Itoh H. Pathological analysis of hypertrophic cardiomyopathy simulating dilated cardiomyopathy. Acta Pathol Jpn 1993;43:304-312.
50. 50. Yutani C, Imakita M, Ishibashi-Ueda H, Hatanaka K, Nagata S, Sakakibara H, Nimura Y. Three autopsy cases of progression of left ventricular dilatation in patients with hypertrophic cardiomyopathy. Am Heart J 1985;109:545-553.
51. 51. Yutani C, Imakita M, Ishibashi-Ueda H, Nagata S, Sakakibara H, Nimura Y. Histopathological study of hypertrophic cardiomyopathy with progression to left ventricular dilatation. Acta Pathol Jpn 1987;37:1041-1052.
52. 52. Kawana A, Imaoka C, Kanemoto N. Evolution of dilated cardiomyopathy from hypertrophic obstructive cardiomyopathy: a case report. J Cardiol 1987;17: 389-398.
53. 53. Hina K, Kusachi S, Iwasaki K, Nogami K, Moritani H, Kita T, Taniguchi G, Tsuji T. Progression of left ventricular enlargement in patients with hypertrophic cardiomyopathy: incidence and prognostic value. Clin Cardiol 1993;16:403-407.
54. 54. Kanemoto N, Kawana A, Imaoka C, Goto Y. A case showing a rare evolution from hypertrophic obstructive cardiomyopathy to "dilated" cardiomyopathy demonstrated by echocardiography. Jpn Heart J 1984;28:445-450.
55. 55. Funakoshi M, Imamura M, Sasaki J, Fukino M, Kawano T, Sasaki Y, Nakashima Y, Motooka T, Fukuda K, Imagawa M, Hiroki T, Arakawa K. Seventeen year follow-up of a patient with hypertrophic cardiomyopathy which progressed to dilated cardiomyopathy. Jpn Heart J 1984;25:805-808.
56. 56. Beder SD, Gutgesell FTP, Mullins CE, McNamara DG. Progression from hypertrophic obstructive cardiomyopathy to congestive cardiomyopathy in a child. Am Heart J 1982;104:155-156.
57. 57. ten Cate FJ, Roelandt J. Progression to left ventricular dilatation in patiefnts with hypertrophic obstructive cardiomyopathy. Am Heart J 1979;97: 762-765.
58. 58. Fighali S, Krajcer Z, Edelman S, Leachman RD. Progression of hypertrophic cardiomyopathy into a hypokinetic left ventricle: higher incidence in patients with midventricular obstruction. J Am Coll Cardiol 1987;9:288-294.
59. 59. Spirito P, Maron BJ, Bonow RO, Epstein SE. Severe functional limitation in patients with hypertrophic cardiomyopathy and only mild localized left ventricular hypertrophy. J Am Coll Cardiol 1986;8:537-544.
60. 60. Ciró E, Maron BJ, Bonow RO, Cannon RO, Epstein SE. Relation between marked changes in outflow tract gradient and disease progression in patients with hypertrophic cardiomyopathy. Am J Cardiol 1984;53:1103-1109.
61. 61. Maron BJ, Epstein SE, Roberts WC. Hypertrophic cardiomyopathy and transmural myocardial infarction without significant atherosclerosis of the extramural coronary arteries. Am J Cardiol 1979;43:1086-1102.
62. 62. Cannon RO, Rosing DR, Maron BJ, Leon MB, Bonow RO, Watson RM, Epstein SE. Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated ventricular filling pressures. Circulation 1985;7:234-243.
63. 63. O'Gara PT, Bonow RO, Maron BJ, Damske BA, van Lingen A, Bacharach SL, Larson SM, Epstein SE. Myocardial perfusion abnormalities in patients with hypertrophic cardiomypathy: assessment with thallium-201 emission computed tomography. Circulation 1987;76:1214-1223.
64. 64. Maron BJ, Wolfson JK, Epstein SE, Roberts WC. Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy. J Am Coll Cardiol 1986;8:545-557.
65. 65. Tanaka M, Fujiwara H, Onodera T, Wu D, Hamashima Y, Kawai C. Quantitative analysis of narrowings of intramyocardial small arteries in normal hearts, hypertensive hearts, and hearts with hypertrophic cardiomyopathy. Circulation 1987;75:1130-1139.
66. 66. Camici P, Chiriatti G, Lorenzoni R, Bellina RC, Gistri R, Italilani G, Parodi O, Salvadri PA, Nista N, Papi L, L'Abbate A. Coronary vasodilatation is impaired in both hypertrophied nonhypertrophied myocardium of patients with hypertrophic cardiomyopathy: a study with nitrogen-13 ammonia and positron emission tomography. J Am Coll Cardiol 1991;17:879-886.
67. 67. Narula J, Haider N, Virmani R, DiSalvo TG, Kolodgie FD, Hajjar RJ, Schmidt U, Semigran MJ, Dec GW, Khaw B-A. Apoptosis in myocytes in end-stage heart failure. N Engl J Med 1996;335:1182-1189.
68. 68. Olivetti G, Abbi R, Quaini F, Kajstura J, Cheng W, Nitahara JA, Quaini E, Di Loreto C, Beltrami CA, Krajewski S, Reed JC, Anversa P. Apoptosis in the failing human heart. N Engl J Med 1997;336:1131-1141.
69. 69. Maron BJ, Hecht G, Klues HG, Kunkes SH, Rosenfeld LE, Cecchid F. Both aborted sudden cardiac death and end-stage phase in hypertrophic cardiomyopathy. Am J Cardiol 1993;72:363-365.
70. 70. Lechin M, Quiñones MA, Omran A, Hill R, Yu Q-T, Rakowski H, Wigle D, Liew CC, Sole M, Roberts R, Marian AJ. Angiotensin-I converting enzyme genotypes and left ventricular hypertrophy in patients with hypertrophic cardiomyopathy. Circulation 1995;92:1808-1812.
71. 71. Shirani J, Maron BJ, Cannon RO, Shakin S, Roberts WC. Clinicopathologic features of hypertrophic cardiomyopathy managed by cardiac transplantation. Am J Cardiol 1993;72:434-440.
72. 72. Spirito P, Maron BJ. Relation between extent of left ventricular hypertrophy and age in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 1989;13:820-823.
73. 73. Lewis JF, Maron BJ. Elderly patients with hypertrophic cardiomyopathy: a subset with distinctive left ventricular morphology and progressive clinical course late in life. J Am Coll Cardiol 1989;13:36-45.
74. 74. Lever HM, Kuram RF, Currie PH, Healy BP. Hypertrophic cardiomyopathy in the elderly. Distinctions from the young based on cardiac shape. Circulation 1989;79:580-589.
75. 75. Fay WP, Taliercio CP, Ilstrup DM, Tajik AJ, Gersh BJ. Natural history of hypertrophic cardiomyopathy in the elderly. J Am Coll Cardiol 1990;16:821-826.
76. 76. Maron BJ, Gross BW, Stark SI. Extreme left ventricular hypertrophy. Circulation 1995;92:2748.
77. 77. Louie EK, Maron BJ. Hypertrophic cardiomyopathy with extreme increase in left ventricular wall thickness: functional and morphologic features and clinical significance. J Am Coll Cardiol 1986;8:57-65.
78. 78. Spirito P, Maron BJ. Relation between extent of left ventricular hypertrophy and occurrence of sudden cardiac death in hypertrophic cardiomyopathy. J Am Coll Cardiol 1990;15:1521-1526.